Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
2.
Toxicol Pathol ; 37(2): 183-92, 2009 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-19182213

RESUMO

The full-thickness wound in the genetically diabetic (db/db) mouse is a commonly used model of impaired wound healing. We investigated delayed healing of non-occluded, excisional, full-thickness, dermal wounds in db/db mice in comparison to their normal littermate controls and refined methods for monitoring skin wound re-epithelialization, contraction, granulation tissue formation, and inflammation. We have confirmed with a computer-assisted planimetry method the results of previous studies showing that healing of non-occluded full excision wounds in db/db mice does not occur by contraction as much as in healthy mice. In addition, we have developed separate histological methods for the assessment of re-epithelialization, contraction, granulation tissue (mature, immature, fibrosis), and inflammation (lipogranulomas, secondary, nonspecific). Using a new approach to histological assessment, we have shown that wound closure in db/db mice is delayed owing to: (1) delayed granulation tissue maturation; (2) ''laced,'' widely distributed granulation tissue around fat lobules; and (3) obstruction by lipogranulomas, whereas the rate of re-epithelialization seems to be the same as in C57Bl/6 mice. This methodology should permit a more precise differentiation of effects of novel therapeutic agents on the wound healing process in db/db mice.


Assuntos
Diabetes Mellitus/patologia , Diabetes Mellitus/fisiopatologia , Pele/lesões , Cicatrização/fisiologia , Ferimentos Penetrantes/patologia , Animais , Feminino , Fibrose/patologia , Tecido de Granulação/patologia , Inflamação/patologia , Camundongos , Camundongos Endogâmicos C57BL , Pele/patologia , Ferimentos Penetrantes/etiologia
4.
Eur J Pharmacol ; 570(1-3): 212-21, 2007 Sep 10.
Artigo em Inglês | MEDLINE | ID: mdl-17628536

RESUMO

Apart from becaplermin (recombinant human platelet-derived growth factor homodimer of B chains, PDGF-BB), for the treatment of lower extremity diabetic ulcers, few agents are available for pharmacological stimulation of wound healing. We have compared the mechanism of action of the potential wound healing agent, PL 14736 (G E P P P G K P A D D A G L V), with that of PDGF-BB on granulation tissue formation following sponge implantation in the normoglycemic rat and in healing full-thickness excisional wounds in db/db genetically diabetic mice. Expression of the immediate response gene, early growth response gene-1 (egr-1) was studied in Caco-2 cells in vitro. While PDGF-BB and PL 14736 had similar selectivity for stimulation of granulation tissue in both sponge granuloma and in healing wounds in db/db mice, PL 14736 was more active in stimulating early collagen organization. It also stimulated expression of egr-1 and its repressor nerve growth factor 1-A binding protein-2 (nab2) in non-differentiated Caco-2 cells more rapidly than PDGF-BB. EGR-1 induces cytokine and growth factor generation and early extracellular matrix (collagen) formation, offering an explanation for the beneficial effects of PL 14736 on wound healing.


Assuntos
Colágeno/metabolismo , Proteína 1 de Resposta de Crescimento Precoce/metabolismo , Tecido de Granulação/efeitos dos fármacos , Fragmentos de Peptídeos/farmacologia , Proteínas/farmacologia , Cicatrização/efeitos dos fármacos , Animais , Becaplermina , Células CACO-2 , Citocinas/metabolismo , Diabetes Mellitus/genética , Diabetes Mellitus/metabolismo , Diabetes Mellitus/patologia , Diabetes Mellitus/fisiopatologia , Proteína 1 de Resposta de Crescimento Precoce/genética , Tecido de Granulação/metabolismo , Tecido de Granulação/patologia , Granuloma de Corpo Estranho/tratamento farmacológico , Granuloma de Corpo Estranho/metabolismo , Granuloma de Corpo Estranho/patologia , Humanos , Camundongos , Camundongos Endogâmicos C57BL , Fragmentos de Peptídeos/uso terapêutico , Fator de Crescimento Derivado de Plaquetas/farmacologia , Proteínas/uso terapêutico , Proteínas Proto-Oncogênicas c-sis , RNA Mensageiro/metabolismo , Ratos , Ratos Wistar , Proteínas Recombinantes/farmacologia , Proteínas Repressoras/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...